Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    19567759 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Pilot Study Comparing Treatment With Dexmedetomidine to Midazolam for Symptom Control in Advanced Cancer Patients
Conditions: Pain Intractable;   Delirium;   Dyspnea;   Nausea
Interventions: Drug: Dexmedetomidine;   Drug: Midazolam
2 Completed Dynamic Light Application to Prevent ICU Acquired Delirium
Conditions: Delirium;   Confusion
Intervention: Other: Dynamic Light

Indicates status has not been verified in more than two years